Koye Pharmaceuticals Pvt ltd
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Glimipack MV 1mg/500mg/0.2mg Tablet is an anti-diabetic drug used to treat type 2 diabetes mellitus in adults by controlling blood sugar levels.
Tablet
Glimipack MV 1mg/500mg/0.2mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. The medicine should be taken with food to avoid an upset stomach and can cause hypoglycemia when used with other antidiabetic medicines, alcohol, or if a meal is delayed or missed. Regular liver function checks may be necessary, and any symptoms like abdominal pain, loss of appetite, or jaundice should be reported to a doctor.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Glimipack MV 1mg/500mg/0.2mg Tablet is to be taken on an empty stomach.
Glimipack MV 1mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines.
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimipack MV 1mg/500mg/0.2mg Tablet is a combination medication containing glimepiride, metformin, and voglibose. It is used to treat type 2 diabetes mellitus (DM) in adults, in conjunction with a healthy diet and regular exercise. Glimepiride increases insulin release from the pancreas, while metformin reduces glucose production in the liver and improves insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose levels. This medication is not suitable for treating type 1 DM.
Common side effects of Glimipack MV 1mg/500mg/0.2mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. If you experience any of these symptoms, consult your doctor or healthcare provider.
Glimipack MV 1mg/500mg/0.2mg Tablet should be avoided in patients with known allergies to its components or excipients. Additionally, it is contraindicated in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis.
No, it is not recommended to consume alcohol while taking Glimipack MV 1mg/500mg/0.2mg Tablet. This may increase the risk of hypoglycemia and lactic acidosis. Consult your doctor or healthcare provider for personalized advice.
Yes, Glimipack MV 1mg/500mg/0.2mg Tablet can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This is more likely to occur if you miss or delay meals, drink alcohol, over-exercise, or take other antidiabetic medications. Regularly monitor your blood sugar levels and keep glucose tablets, honey, or fruit juice nearby.
Store Glimipack MV 1mg/500mg/0.2mg Tablet in its original packaging, tightly closed. Follow the storage instructions provided on the packaging or label. Dispose of unused medication properly, ensuring it is not consumed by pets, children, or other individuals.